Localization of thymidine phosphorylase in breast cancer tissue

Med Mol Morphol. 2005 Jun;38(2):112-7. doi: 10.1007/s00795-005-0282-7.

Abstract

Thymidine phosphorylase levels are higher in some human cancer tissues than in adjacent normal tissue. However, the ultrastructural localization of thymidine phosphorylase in cancer tissue has been demonstrated only in advanced gastric and colorectal cancer. We investigated the localization of thymidine phosphorylase in breast cancer tissue by immunohistochemistry and its ultrastructural localization by immunoelectron microscopy. Surgically resected specimens from 30 cases of breast cancer were analyzed. Immunohistochemical analysis revealed that cancer cells were positive in 13 cases. However, there were 21 cases that showed thymidine phosphorylase-positive inflammatory cells in cancer tissue. Thymidine phosphorylase-positive staining was detected among both cancer cells and inflammatory cells in 11 cases. Thymidine phosphorylase was diffusely positive in the cytoplasm of cancer cells and specifically positive in mitochondria of neutrophils and specific cytoplasmic granules of macrophages in cancer tissue by immunoelectron microscopy. These findings suggest that thymidine phosphorylase is produced by macrophages and is present in mitochondria of neutrophils and cytoplasmic granules of cancer cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 5'-Nucleotidase / analysis*
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / enzymology*
  • Breast Neoplasms / ultrastructure
  • Capecitabine
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / metabolism
  • Female
  • Fluorouracil / analogs & derivatives
  • Humans
  • Immunohistochemistry
  • Microscopy, Immunoelectron

Substances

  • Deoxycytidine
  • Capecitabine
  • 5'-Nucleotidase
  • Fluorouracil